Thanks for visiting! Welcome to a new way to research case law. You are viewing a free summary from Descrybe.ai. For citation and good law / bad law checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.
Invitrogen Corp. v. Biocrest Manufacturing
Citation: Not availableDocket: 2004-1273
Court: Court of Appeals for the Federal Circuit; October 5, 2005; Federal Appellate Court
Original Court Document: View Document
On October 5, 2005, the United States Court of Appeals for the Federal Circuit issued an erratum for Appeal No. 04-1273,-1274, involving Invitrogen Corp. and Biocrest Mfg. L.P., as well as Stratagene Holding Corp. and Stratagene, Inc. The corrections made to the precedential opinion include: - On page 7, line 20, the name "Stratagene" was replaced with "Invitrogen." - On page 7, line 23, "Stratagene" was again substituted with "Invitrogen." - On page 8, line 2, "Stratagene’s" was changed to "Invitrogen’s." - On page 8, line 5, "Stratagene" was modified to "Invitrogen." These amendments ensure the accurate representation of the parties involved in the case.